[Management of amebic dysentery and its complications with resotren comp].
D000562:Amebiasis; D000971:Antineoplastic Combined Chemotherapy Protocols; D002738:Chloroquine / Q000627:therapeutic use*; D003520:Cyclophosphamide; D004404:Dysentery, Amebic / Q000628:therapy*; D006801:Humans; D006912:Hydroxyquinolines / Q000627:therapeutic use*; D004103:Iodoquinol / Q000627:therapeutic use*; D008727:Methotrexate; D011241:Prednisone; D014750:Vincristine
D006912:Hydroxyquinolines; D014750:Vincristine; D004103:Iodoquinol; D002738:Chloroquine; D003520:Cyclophosphamide; D011241:Prednisone; D008727:Methotrexate
AMEBIASIS, INTESTINAL/therapy; CHINIOFON/therapeutic use; CHLOROQUINE/therapeutic use; DIIODOHYDROXYQUINOLINE/therapeutic use
Die Behandlung der Amoebendysenterie und ihrer Folgezustände mit Resotren comp.